المؤلفون: Chew C.Y., Saracino A.M., Nikpour M., Mar A.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
Click here for full text options
LibKey Link

المؤلفون: Chew C.Y., Saracino A.M., Nikpour M., Mar A.

مصطلحات الفهرس: drug absorption, drug bioavailability, drug contraindication, drug efficacy, drug metabolism, drug safety, erythema annulare centrifugum/si [Side Effect], erythema multiforme/si [Side Effect], eye examination, gastrointestinal symptom/si [Side Effect], giant cell granuloma/dt [Drug Therapy], glioblastoma/dt [Drug Therapy], glucose 6 phosphate dehydrogenase deficiency, granuloma annulare/dt [Drug Therapy], heart protection, heartburn/si [Side Effect], human, hyperpigmentation/si [Side Effect], hypertransaminasemia/si [Side Effect], hypoglycemia/si [Side Effect], immunomodulation, irritability, leukopenia/si [Side Effect], lichen (disease)/dt [Drug Therapy], lichen planus/dt [Drug Therapy], lichen sclerosus et atrophicus/dt [Drug Therapy], liver toxicity/si [Side Effect], lung cancer/dt [Drug Therapy], lupus vulgaris/dt [Drug Therapy], measles like rash/si [Side Effect], melanoma/dt [Drug Therapy], mood change, morphea/dt [Drug Therapy], mucinosis/dt [Drug Therapy], multiple myeloma/dt [Drug Therapy], nausea/si [Side Effect], necrobiosis lipoidica/dt [Drug Therapy], nightmare/si [Side Effect], nonhuman, outcome assessment, pancreas cancer/dt [Drug Therapy], panniculitis/dt [Drug Therapy], patient monitoring, pharmacodynamics, photodermatosis/dt [Drug Therapy], porphyria cutanea tarda/dt [Drug Therapy], practice guideline, pregnancy, prescription, pruritus/si [Side Effect], psoriasis/si [Side Effect], rash/si [Side Effect], retina maculopathy/si [Side Effect], retinopathy/si [Side Effect], review, risk benefit analysis, risk reduction, sarcoma/dt [Drug Therapy], side effect/si [Side Effect], skin contusion/si [Side Effect], skin sarcoidosis/dt [Drug Therapy], smoking, solid malignant neoplasm/dt [Drug Therapy], Stevens Johnson syndrome/si [Side Effect], systemic lupus erythematosus/dt [Drug Therapy], systemic sclerosis/dt [Drug Therapy], toxic epidermal necrolysis/si [Side Effect], treatment response, urticaria/si [Side Effect], vasculitis/dt [Drug Therapy], visual impairment/si [Side Effect], vomiting/si [Side Effect], cyclosporine/it [Drug Interaction], digoxin/it [Drug Interaction], glucose 6 phosphate dehydrogenase/ec [Endogenous Compound], hydroxychloroquine/ae [Adverse Drug Reaction], hydroxychloroquine/it [Drug Interaction], hydroxychloroquine/dt [Drug Therapy], hydroxychloroquine/pk [Pharmacokinetics], hydroxychloroquine/pd [Pharmacology], methotrexate/it [Drug Interaction], follicular mucinosis/dt [Drug Therapy], lichen planopilaris/dt [Drug Therapy], reticular erythematous mucinosis/dt [Drug Therapy], urticarial vasculitis/dt [Drug Therapy], laboratory test, abdominal distension/si [Side Effect], acute generalized exanthematous pustulosis/si [Side Effect], agranulocytosis/si [Side Effect], alopecia/si [Side Effect], alopecia areata/dt [Drug Therapy], anorexia/si [Side Effect], antineoplastic activity, antiphospholipid syndrome/dt [Drug Therapy], antithrombotic activity, aplastic anemia/si [Side Effect], blood toxicity/si [Side Effect], chronic urticaria/dt [Drug Therapy], dermatology, dermatomyositis/dt [Drug Therapy], diarrhea/si [Side Effect], DRESS syndrome/si [Side Effect], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35375
Australasian Journal of Dermatology
LibKey Link

المؤلفون: Stark Z., Hunter M.F., Low M.S.Y., Bryant V.L., Watson L.R., Slade C.A., Ojaimi S., Barnes S., Fedele P., Smith P., Marum J., Lunke S.

مصطلحات الفهرس: immunoglobulin deficiency/dt [Drug Therapy], incidental finding, interstitial lung disease/si [Side Effect], low drug dose, lower respiratory tract infection/co [Complication], lymphocytopenia/si [Side Effect], melanoma/co [Complication], missense mutation, multiple sclerosis/dt [Drug Therapy], myeloblast, nausea/si [Side Effect], nuclear magnetic resonance imaging, tachycardia/si [Side Effect], treatment withdrawal, uterine cervix carcinoma in situ/co [Complication], vomiting/si [Side Effect], whole exome sequencing, young adult, budesonide/dt [Drug Therapy], budesonide/po [Oral Drug Administration], C reactive protein/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cytotoxic T lymphocyte antigen 4/ec [Endogenous Compound], daclizumab/ae [Adverse Drug Reaction], daclizumab/dt [Drug Therapy], fingolimod/ae [Adverse Drug Reaction], fingolimod/dt [Drug Therapy], fumaric acid dimethyl ester/ae [Adverse Drug Reaction], fumaric acid dimethyl ester/dt [Drug Therapy], HLA DQ2 antigen/ec [Endogenous Compound], methotrexate/dt [Drug Therapy], natalizumab/ae [Adverse Drug Reaction], natalizumab/dt [Drug Therapy], prednisolone/do [Drug Dose], prednisolone/dt [Drug Therapy], CTLA4 gene, lymphocytic enteritis/co [Complication], lymphocytic enteritis/dt [Drug Therapy], enteritis/co [Complication], adult, agranulocytosis/si [Side Effect], allergic rhinitis, article, asthma, atopy, Australian, bone marrow biopsy, case report, clinical article, cyanocobalamin deficiency/co [Complication], drug withdrawal, eczema, enteritis/dt [Drug Therapy], febrile neutropenia/si [Side Effect], female, fever/si [Side Effect], genetic analysis, haploinsufficiency, heterozygosity, human, human tissue, idiopathic thrombocytopenic purpura/si [Side Effect], immunoglobulin deficiency/di [Diagnosis], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37569
Allergy, Asthma and Clinical Immunology
Click here for full text options
LibKey Link

المؤلفون: Bowden D.K., Ho P.J., Tay L., Lindeman R., Catley L.

مصطلحات الفهرس: iron chelation, iron overload, kidney function, lactation, liver biopsy, liver function test, lumpy skin disease/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], nuclear magnetic resonance imaging, ototoxicity/si [Side Effect], pathophysiology, practice guideline, pregnancy, priority journal, rash/si [Side Effect], sickle cell anemia, side effect/si [Side Effect], thalassemia major, deferasirox/ae [Adverse Drug Reaction], deferasirox/po [Oral Drug Administration], deferiprone/ae [Adverse Drug Reaction], deferiprone/cb [Drug Combination], deferiprone/po [Oral Drug Administration], deferoxamine/ae [Adverse Drug Reaction], deferoxamine/cb [Drug Combination], deferoxamine/iv [Intravenous Drug Administration], ferritin/ec [Endogenous Compound], iron/ec [Endogenous Compound], transferrin/ec [Endogenous Compound], deferoxamine/sc [Subcutaneous Drug Administration], agranulocytosis/si [Side Effect], anemia, arthralgia/si [Side Effect], arthritis/si [Side Effect], article, blood transfusion, cardiomyopathy, cardiovascular risk, computer assisted tomography, diarrhea/si [Side Effect], drug efficacy, ferritin blood level, gastrointestinal symptom/si [Side Effect], heart ejection fraction, human, infection risk, injection site infection/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30401
Click here for full text options
LibKey Link

المؤلفون: Vaddadi G., Vaddadi K.S., Soosai E.

مصطلحات الفهرس: schizophrenia/dt [Drug Therapy], selenium deficiency/si [Side Effect], trace metal blood level, clozapine/ae [Adverse Drug Reaction], clozapine/do [Drug Dose], clozapine/dt [Drug Therapy], clozapine/pd [Pharmacology], selenium/cr [Drug Concentration], myocarditis/si [Side Effect], adult, agranulocytosis/si [Side Effect], article, blood sampling, cardiomyopathy/si [Side Effect], catecholamine metabolism, dietary intake, female, human, major clinical study, male, oxidative stress, priority journal, risk benefit analysis, schizophrenia/di [Diagnosis], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32693
Click here for full text options
LibKey Link

المؤلفون: Yamin S., Vaddadi K.

مصطلحات الفهرس: functional assessment, human, hypersalivation/si [Side Effect], insulin resistance/si [Side Effect], low drug dose, maintenance therapy, metabolic syndrome X/si [Side Effect], negative syndrome/si [Side Effect], neutrophil count, patient compliance, polypharmacy, priority journal, review, schizophrenia/dt [Drug Therapy], schizophrenia/th [Therapy], sedation, side effect/si [Side Effect], social psychology, tardive dyskinesia/si [Side Effect], weight gain, atypical antipsychotic agent/ae [Adverse Drug Reaction], atypical antipsychotic agent/cm [Drug Comparison], chlorpromazine, clozapine/ae [Adverse Drug Reaction], clozapine/dt [Drug Therapy], flupentixol decanoate/ae [Adverse Drug Reaction], flupentixol decanoate/do [Drug Dose], fluphenazine decanoate/ae [Adverse Drug Reaction], fluphenazine decanoate/ct [Clinical Trial], fluphenazine decanoate/dt [Drug Therapy], fluphenazine enanthate/ct [Clinical Trial], fluphenazine enanthate/dt [Drug Therapy], haloperidol, neuroleptic agent/ae [Adverse Drug Reaction], neuroleptic agent/cm [Drug Comparison], neuroleptic agent/dt [Drug Therapy], olanzapine/ae [Adverse Drug Reaction], perphenazine/ae [Adverse Drug Reaction], placebo, quetiapine, risperidone, thioridazine, lifestyle, agranulocytosis/si [Side Effect], anhedonia, clinical protocol, clinical trial, drug dose comparison, drug dose reduction, drug dose regimen, drug fatality/si [Side Effect], drug megadose, drug use, drug withdrawal, dysphoria/si [Side Effect], extrapyramidal symptom/si [Side Effect], family therapy, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30990
Click here for full text options
LibKey Link

المؤلفون: Bowden D.K., Ho P.J., Tay L., Lindeman R., Catley L.

مصطلحات الفهرس: iron chelation, iron overload, kidney function, lactation, liver biopsy, liver function test, lumpy skin disease/si [Side Effect], nausea/si [Side Effect], neutropenia/si [Side Effect], nuclear magnetic resonance imaging, ototoxicity/si [Side Effect], pathophysiology, practice guideline, pregnancy, priority journal, rash/si [Side Effect], sickle cell anemia, side effect/si [Side Effect], thalassemia major, deferasirox/ae [Adverse Drug Reaction], deferasirox/po [Oral Drug Administration], deferiprone/ae [Adverse Drug Reaction], deferiprone/cb [Drug Combination], deferiprone/po [Oral Drug Administration], deferoxamine/ae [Adverse Drug Reaction], deferoxamine/cb [Drug Combination], deferoxamine/iv [Intravenous Drug Administration], ferritin/ec [Endogenous Compound], iron/ec [Endogenous Compound], transferrin/ec [Endogenous Compound], deferoxamine/sc [Subcutaneous Drug Administration], agranulocytosis/si [Side Effect], anemia, arthralgia/si [Side Effect], arthritis/si [Side Effect], article, blood transfusion, cardiomyopathy, cardiovascular risk, computer assisted tomography, diarrhea/si [Side Effect], drug efficacy, ferritin blood level, gastrointestinal symptom/si [Side Effect], heart ejection fraction, human, infection risk, injection site infection/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30401
LibKey Link

المؤلفون: Vaddadi G., Vaddadi K.S., Soosai E.

مصطلحات الفهرس: schizophrenia/dt [Drug Therapy], selenium deficiency/si [Side Effect], trace metal blood level, clozapine/ae [Adverse Drug Reaction], clozapine/do [Drug Dose], clozapine/dt [Drug Therapy], clozapine/pd [Pharmacology], selenium/cr [Drug Concentration], myocarditis/si [Side Effect], adult, agranulocytosis/si [Side Effect], article, blood sampling, cardiomyopathy/si [Side Effect], catecholamine metabolism, dietary intake, female, human, major clinical study, male, oxidative stress, priority journal, risk benefit analysis, schizophrenia/di [Diagnosis], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32693
LibKey Link

المؤلفون: Yamin S., Vaddadi K.

مصطلحات الفهرس: functional assessment, human, hypersalivation/si [Side Effect], insulin resistance/si [Side Effect], low drug dose, maintenance therapy, metabolic syndrome X/si [Side Effect], negative syndrome/si [Side Effect], neutrophil count, patient compliance, polypharmacy, priority journal, review, schizophrenia/dt [Drug Therapy], schizophrenia/th [Therapy], sedation, side effect/si [Side Effect], social psychology, tardive dyskinesia/si [Side Effect], weight gain, atypical antipsychotic agent/ae [Adverse Drug Reaction], atypical antipsychotic agent/cm [Drug Comparison], chlorpromazine, clozapine/ae [Adverse Drug Reaction], clozapine/dt [Drug Therapy], flupentixol decanoate/ae [Adverse Drug Reaction], flupentixol decanoate/do [Drug Dose], fluphenazine decanoate/ae [Adverse Drug Reaction], fluphenazine decanoate/ct [Clinical Trial], fluphenazine decanoate/dt [Drug Therapy], fluphenazine enanthate/ct [Clinical Trial], fluphenazine enanthate/dt [Drug Therapy], haloperidol, neuroleptic agent/ae [Adverse Drug Reaction], neuroleptic agent/cm [Drug Comparison], neuroleptic agent/dt [Drug Therapy], olanzapine/ae [Adverse Drug Reaction], perphenazine/ae [Adverse Drug Reaction], placebo, quetiapine, risperidone, thioridazine, lifestyle, agranulocytosis/si [Side Effect], anhedonia, clinical protocol, clinical trial, drug dose comparison, drug dose reduction, drug dose regimen, drug fatality/si [Side Effect], drug megadose, drug use, drug withdrawal, dysphoria/si [Side Effect], extrapyramidal symptom/si [Side Effect], family therapy, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30990
LibKey Link